Galectin 10 Protein (AA 1-142) (His tag)

Produktnummer ABIN667436

Dieses Recombinant Galectin 10-Protein wird in Escherichia coli (E. coli) produziert.

Kurzübersicht für Galectin 10 Protein (AA 1-142) (His tag) (ABIN667436)

Target: Galectin 10 (CLC) (Charcot-Leyden Crystal Protein (CLC))

Protein-Typ: Recombinant

Spezies: Human

Quelle: Escherichia coli (E. coli)

Applikation: SDS-PAGE (SDS)

Reinheit: > 90 % by SDS - PAGE

Produktdetails

Proteineigenschaft: AA 1-142

Aufreinigungstag / Konjugat: Dieses Galectin 10 Protein ist gelabelt mit His tag.

Produktmerkmale: CLC, 1-142aa, Human, His tag, E.coli

Anwendungsinformationen

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 0.5 mg/ml (determined by Bradford assay)

Buffer: Liquid. In 20mM Tris-HCl buffer (pH 8.0) containing 1mM DTT, 10% glycerol, 0.1M NaCl

Lagerung: 4 °C

Antigendetails

Target: Galectin 10 (CLC) (Charcot-Leyden Crystal Protein (CLC))

Andere Bezeichnung: CLC

Hintergrund: Eosinophil lysophospholipase (CLC), also known as Galectin 10, act on biological membranes to regulate the multifunctional lysophospholipids. CLC is a lysophospholipase expressed in eosinophils and basophils. It hydrolyzes lysophosphatidylcholine to glycerophosphocholine and a free fatty acid. This protein may possess carbohydrate or IgE-binding activities. It is both structurally and functionally related to the galectin family of beta-galactoside binding proteins. It may be associated with inflammation and some myeloid leukemias. Recombinant human CLC protein, fused to His-tag at N-terminus, was expressed in E.coli and purified by using conventional chromatography techniques. Synonyms: Eosinophil lysophospholipase, Galectin 10, Gal-10, GAL10, LGALS10, LGALS10A, LPPL. NCBI no.: NP_001819

Molekulargewicht: 18.6 kDa (162aa) confirmed by MALDI-TOF

Pathways: Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response